Promising Research Developments Stir Hopes for Melanoma, Lung, Breast and Ovarian Cancer

The growing excitement about the potential of immunotherapy treatments for cancer continued at the 2015 meeting of the American Association for Cancer Research (AACR), one of the largest cancer research meetings of the year. Several Dana-Farber investigators presented encouraging results of immunotherapy for melanoma, lung cancer, and breast cancer. F. Stephen Hodi, MD, and Leena … Read more

New Immunotherapy Vaccines Show Promise in Treating Brain Tumors

Researchers in Dana-Farber’s Center for Neuro-Oncology are now launching attacks on glioblastomas from a new angle – by turning the patient’s immune system against the cancer cells. Where targeted chemotherapy uses drugs to disable proteins that cancer cells need to grow, immunotherapy drugs stimulate the patient’s immune system to recognize and kill cancer cells. Traditional drugs … Read more

New Therapy for ‘Bubble Boy’ Disease Gives Chilean Boy a Chance for a Healthy Life

Gabriel Solis is a typical 3-year-old. He likes puzzles and swimming and singing. He shakes off colds like other children. Gabriel, however, is not like other children. He has a functioning immune system thanks to an international gene therapy trial for “bubble boy” disease whose early success was reported recently in the New England Journal … Read more

Themed Chemo Visits Help Breast Cancer Patient Cope with Treatment

Cancer treatment is never fun, but Cheryl St. Onge figures if she has to go through it, she’s doing it with style — and smiles. Each time the breast cancer patient arrives at Dana-Farber/Brigham and Women’s Cancer Center at Milford Regional Medical Center for her infusion visit, she wears a different themed outfit. One time … Read more

New Strategies in Treating Kidney Cancer

Though quite curable when diagnosed early, kidney cancer in advanced stages can become a stubborn disease. However, the outlook for patients with metastatic kidney cancer has brightened in the past several years. Oncologists have added to their arsenal a number of designer drugs that attack molecular targets – genetic abnormalities that drive tumors – with … Read more

Ask the Expert: Questions and Answers about Brain Tumors

Dana-Farber Cancer Institute recently partnered with CancerConnect and Lakshmi Nayak, MD, to answer questions about brain cancer. Nayak is a neuro-oncologist in the Center for Neuro-Oncology at Dana-Farber/Brigham and Women’s Cancer Center and an instructor in neurology at Harvard Medical School.  Q: There seems to be some progress concerning treatment of brain tumors, especially immunotherapy. … Read more